Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Description

There is on-going development of  generic EU CTD Dossier of Risedronate, tablets, 5/30/35 mg.


Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Risedronic acid (INN) or risedronate sodium (USAN, trade name Actonel) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.

More details at: http://www.rxlist.com/actonel-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 41

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I want to give process knowhow and NON GMO...
n/a
89 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
231 Views
 Company portfolio: Manufacturing over 100...
446 Views
Objective: To enter into EU domain procuring...
471 Views
Objective: To enter into EU domain grabbing a...
218 Views
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF...
255 Views
Please contact me.  if you need...
733 Views